Advertisement

Search Results

Advertisement



Your search for Sara A. Hurvitz, MD, FACP, and Shiliang Zhang, MD,Sara A. Hurvitz, MD, FACP, and Shiliang Zhang, MD matches 1 pages

Showing 1 - 1


breast cancer
immunotherapy

Margetuximab-cmkb: A Novel Agent Overshadowed by an Abundance of Options in HER2-Positive Breast Cancer

It is incredible to reflect upon the scientific advances in the treatment of HER2-positive breast cancer over the past 23 years. Once considered the worst subtype of breast cancer, HER2-positive disease is now associated with the best long-term outcomes in this age of targeted treatments. With a...

Advertisement

Advertisement




Advertisement